Exclusive special offer and discount title banner vector image

CHINA BOTULINUM TOXIN MARKET FORECAST 2023-2030

SCOPE OF THE REPORT

China Botulinum Toxin Market by Type (Type A Botulinum Toxin, Type B Botulinum Toxin) Market by User Demographic (Women, Men) Market by Application (Medical (Chronic Migraine, Muscle Spasm, Overactive Bladder, Hyperhidrosis, Other Medical Applications), Aesthetic (Crow’s Feet, Forehead Lines, Frown Lines/glabellar, Square Jaw/masseter, Other Aesthetic Applications)) Market by End-user (Specialty and Dermatology Clinics, Hospitals and Clinics, Other End-users)


MARKET OVERVIEW

The China botulinum toxin market is projected to generate $752.32 million in revenue by 2030, and is anticipated to grow with a 10.31% CAGR during the estimation period, 2023-2030.

In China, the demand for medical beauty treatments is increasing due to economic growth, rising incomes, and changing consumption habits. Botulinum toxin type A is commonly used for medical purposes such as treating adult blepharospasm, prosopospasm, and certain types of strabismus. The incidence of facial neuropathy is also rising in China, with more women seeking treatments for thinning their faces or reducing wrinkles. 

In 2021, the medical aesthetics market in China amounted to $31.63 billion, which is still growing. However, some medical institutions and beauty salons have been found to use smuggled botulinum toxin type A products from countries like South Korea, France, and Germany. Although only Botox and Hengli are approved for sale in China, these smuggled products are easily available. It is crucial to ensure the safety and efficacy of such products, and the government should take strict measures to prevent their use. Despite the challenges, the growing demand for medical aesthetics treatments in China presents a significant opportunity for companies in this sector.

To Know More About This Report, Request a Free Sample Copy

The China botulinum toxin market segmentation analysis entails user application, end-user, demographic, and type. Market by user demographic includes women and men.

In recent years, there has been a rise in the number of men opting for cosmetic procedures, as per studies. While women still constitute a significant majority of patients, men have shown a consistent upward trend in opting for such procedures. The declining stigma surrounding cosmetic surgery, the wider availability of treatments, and the increasing affordability of these treatments have all contributed to this trend. Minimally invasive procedures that require little or no recovery time are especially popular among men, with botulinum toxin being one of the most widely used treatments in 2020. 

The American Society of Plastic Surgeons reported that male patients underwent nearly 265,000 botulinum toxin treatments alone in 2020. These procedures are so popular among men that they have been named “Brotox.” The increasing desire for natural-looking results is another crucial consideration for men opting for minimally invasive procedures. These treatments typically require minimal aftercare, allowing patients to return to their daily routine quickly. The demand for minimally invasive cosmetic procedures is expected to continue rising among men in the coming years.

Leading players in the China botulinum toxin market include Lanzhou Institute of Biological Products Co Ltd, Daewoong Pharmaceutical Co Ltd, etc.

Lanzhou Institute of Biological Products Co Ltd, a leading Chinese biological products research institute, is renowned for its production, research, development, and operation of preventive products, therapeutic products, and diagnostic reagents, amongst other biological products. The company has a strong customer base, providing it with a competitive edge and strengthening its position in the industry. The company is committed to developing innovative solutions by integrating new technologies, catering to its customer’s demands and needs, and expanding its operations.

The company has six specialized research labs, including one pilot research lab, enabling the formation of unique scientific research subjects and directions. The company’s primary products include an oral live rotavirus vaccine, group A and group C meningococcal polysaccharide vaccine, and Haemophilus influenzae type b conjugate vaccine. The company has established cooperative relations with renowned research institutions worldwide, such as the United States, Japan, Italy, Britain, and Hong Kong. Lanzhou Institute of Biological Products Co Ltd is headquartered in Gansu, China.

Lanzhou Institute of Biological Products Co Ltd’s botulinum toxin type A injection contains crystalline botulinum toxin type A active ingredient, which, upon reconstitution with sodium chloride injection, turns into a colorless or light yellow clear liquid. The injection treats adult patients with blepharospasm, hemifacial spasm, certain strabismus, and moderate to severe frown lines caused by corrugator and procerus muscle activity.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2030
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments Analyzed
Type, User Demographic, Application, and End-User
Countries AnalyzedChina
Companies Analyzed

AbbVie Inc, Daewoong Pharmaceutical Co Ltd, Evolus Inc, Galderma, Lanzhou Institute of Biological Products Co Ltd

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. COUNTRY SNAPSHOT
    3. COUNTRY ANALYSIS
    4. SCOPE OF STUDY
    5. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON BOTULINUM TOXIN MARKET
    6. MAJOR MARKET FINDINGS
      1. FAVORABLE REGULATORY APPROVALS ADD TO MARKET GROWTH
      2. GROWING AWARENESS ABOUT ‘NOTOX’
      3. INFLATING COSMETIC TOURISM ADDS TO THE DEMAND FOR BOTULINUM TOXIN
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. SURGE IN DEMAND FOR AESTHETIC PROCEDURES
      2. RISING GERIATRIC POPULATION
      3. GROWING DEMAND FOR NON-INVASIVE COSMETIC PROCEDURES 
    2. KEY RESTRAINTS
      1. CONCERNS REGARDING THE ADVERSE EFFECTS OF BOTULINUM TOXIN
      2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
    2. PESTLE ANALYSIS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    4. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR CHINA
    5. MARKET MATURITY ANALYSIS
    6. MARKET CONCENTRATION ANALYSIS
  5. MARKET BY TYPE
    1. TYPE A BOTULINUM TOXIN
    2. TYPE B BOTULINUM TOXIN
  6. MARKET BY USER DEMOGRAPHIC
    1. WOMEN
    2. MEN
  7. MARKET BY APPLICATION
    1. MEDICAL
      1. CHRONIC MIGRAINE
      2. MUSCLE SPASM
      3. OVERACTIVE BLADDER
      4. HYPERHIDROSIS
      5. OTHER MEDICAL APPLICATIONS
    2. AESTHETIC
      1. CROW’S FEET
      2. FOREHEAD LINES
      3. FROWN LINES/GLABELLAR
      4. SQUARE JAW/MASSETER
      5. OTHER AESTHETIC APPLICATIONS
  8. MARKET BY END-USER
    1. SPECIALTY AND DERMATOLOGY CLINICS
    2. HOSPITALS AND CLINICS
    3. OTHER END-USERS
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS
      4. BUSINESS EXPANSIONS
    2. COMPANY PROFILES
      1. ABBVIE
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      2. DAEWOONG PHARMACEUTICAL CO LTD
        1. COMPANY PROFILE
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      3. EVOLUS INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      4. GALDERMA
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      5. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: CHINA MARKET SNAPSHOT – BOTULINUM TOXIN

TABLE 2: EXAMPLE OF COMMERCIALLY AVAILABLE BOTULINUM TOXIN TYPE A FOR AESTHETIC PROCEDURES

TABLE 3: CHINA BOTULINUM TOXIN MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 4: CHINA BOTULINUM TOXIN MARKET, BY TYPE, FORECAST YEARS, 2023-2030 (IN $ MILLION)

TABLE 5: CHINA BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 6: CHINA BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, FORECAST YEARS, 2023-2030 (IN $ MILLION)

TABLE 7: CHINA BOTULINUM TOXIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 8: CHINA BOTULINUM TOXIN MARKET, BY APPLICATION, FORECAST YEARS, 2023-2030 (IN $ MILLION)

TABLE 9: CHINA BOTULINUM TOXIN MARKET, BY MEDICAL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 10: CHINA BOTULINUM TOXIN MARKET, BY MEDICAL, FORECAST YEARS, 2023-2030 (IN $ MILLION)

TABLE 11: CHINA BOTULINUM TOXIN MARKET, BY AESTHETIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 12: CHINA BOTULINUM TOXIN MARKET, BY AESTHETIC, FORECAST YEARS, 2023-2030 (IN $ MILLION)

TABLE 13: CHINA BOTULINUM TOXIN MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 14: CHINA BOTULINUM TOXIN MARKET, BY END-USER, FORECAST YEARS, 2023-2030 (IN $ MILLION)

TABLE 15: CHINA BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK

TABLE 16: KEY PLAYERS OPERATING IN CHINA BOTULINUM TOXIN MARKET

TABLE 17: LIST OF ACQUISITIONS

TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 19: LIST OF PARTNERSHIPS

TABLE 20: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR CHINA

FIGURE 4: MARKET MATURITY ANALYSIS

FIGURE 5: MARKET CONCENTRATION ANALYSIS

FIGURE 6: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022

FIGURE 7: CHINA BOTULINUM TOXIN MARKET, BY TYPE A BOTULINUM TOXIN, 2023-2030 (IN $ MILLION)

FIGURE 8: CHINA BOTULINUM TOXIN MARKET, BY TYPE B BOTULINUM TOXIN, 2023-2030 (IN $ MILLION)

FIGURE 9: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY USER DEMOGRAPHIC, IN 2022

FIGURE 10: CHINA BOTULINUM TOXIN MARKET, BY WOMEN, 2023-2030 (IN $ MILLION)

FIGURE 11: CHINA BOTULINUM TOXIN MARKET, BY MEN, 2023-2030 (IN $ MILLION)

FIGURE 12: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022

FIGURE 13: CHINA BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)

FIGURE 14: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY MEDICAL, IN 2022

FIGURE 15: CHINA BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2023-2030 (IN $ MILLION)

FIGURE 16: CHINA BOTULINUM TOXIN MARKET, BY MUSCLE SPASM, 2023-2030 (IN $ MILLION)

FIGURE 17: CHINA BOTULINUM TOXIN MARKET, BY OVERACTIVE BLADDER, 2023-2030 (IN $ MILLION)

FIGURE 18: CHINA BOTULINUM TOXIN MARKET, BY HYPERHIDROSIS, 2023-2030 (IN $ MILLION)

FIGURE 19: CHINA BOTULINUM TOXIN MARKET, BY OTHER MEDICAL APPLICATIONS, 2023-2030 (IN $ MILLION)

FIGURE 20: CHINA BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $ MILLION)

FIGURE 21: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY AESTHETIC, IN 2022

FIGURE 22: CHINA BOTULINUM TOXIN MARKET, BY CROW’S FEET, 2023-2030 (IN $ MILLION)

FIGURE 23: CHINA BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2023-2030 (IN $ MILLION)

FIGURE 24: CHINA BOTULINUM TOXIN MARKET, BY FROWN LINES/GLABELLAR, 2023-2030 (IN $ MILLION)

FIGURE 25: CHINA BOTULINUM TOXIN MARKET, BY SQUARE JAW/MASSETER, 2023-2030 (IN $ MILLION)

FIGURE 26: CHINA BOTULINUM TOXIN MARKET, BY OTHER AESTHETIC APPLICATIONS, 2023-2030 (IN $ MILLION)

FIGURE 27: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022

FIGURE 28: CHINA BOTULINUM TOXIN MARKET, BY SPECIALTY AND DERMATOLOGY CLINICS, 2023-2030 (IN $ MILLION)

FIGURE 29: CHINA BOTULINUM TOXIN MARKET, BY HOSPITALS AND CLINICS, 2023-2030 (IN $ MILLION)

FIGURE 30: CHINA BOTULINUM TOXIN MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)

FAQ’s